Učitavanje...
IVIG May Be An Effective Therapy for Refractory, Active Diffuse Cutaneous Scleroderma
OBJECTIVE: We sought to retrospectively review a single-center experience using intravenous immunoglobulin (IVIG) for the treatment of refractory, active diffuse cutaneous scleroderma. METHODS: The mean modified Rodnan skin score (mRSS) at baseline was compared to the mRSS at 6, 12, 18 and 24 months...
Spremljeno u:
| Izdano u: | J Rheumatol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4314512/ https://ncbi.nlm.nih.gov/pubmed/25433527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.140833 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|